Articles related to SCHIZOPHRENIA

Clozapine did not show superior efficacy compared to second-generation antipsychotics in treatment-resistant schizophrenia.

Expert psychiatric nurse practitioners stress the importance of familiarity with product inserts for each long-acting injectable antipsychotic to effectively manage missed doses in schizophrenia treatment.

Erzofri offers a new once-monthly injectable option for treating schizophrenia and schizoaffective disorder, potentially improving medication adherence for some patients.

Schizophrenia is a chronic brain disorder characterized by hallucinations, delusions, and cognitive impairments, affecting up to 1 percent of the global population. Understanding its symptoms, causes, and treatment options is crucial for effective patient care.

This recent Supreme Court ruling sheds light on the critical intersection of mental health and legal standards, offering an essential perspective for healthcare professionals involved in forensic or psychiatric fields.

The Johns Hopkins Clozapine Consultation Clinic is addressing the critical underutilization of clozapine in treatment-resistant schizophrenia, providing essential support and education for healthcare providers in navigating its benefits and risks.